Gender-affirming therapy using medroxyprogesterone acetate has few side affects

10 May 2019


According to research published in the Journal of Clinical Endocrinology and Metabolism, the use of medroxyprogesterone acetate in transgender women significantly reduces testosterone without impacting estradiol levels.

Endocrinology Advisor


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story